(Q54480934)

30 May 2018

title

Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases. (English)

1 reference

30 May 2018

8

Sanghoon Jheon

1 reference

30 May 2018

Choon-Taek Lee

9

object named as

Choon-Taek Lee

1 reference

30 May 2018

author name string

Hyojin Kim

1

1 reference

30 May 2018

Xianhua Xu

2

1 reference

30 May 2018

Seol-Bong Yoo

3

1 reference

30 May 2018

Ping-Li Sun

4

1 reference

30 May 2018

Yan Jin

5

1 reference

30 May 2018

Jin Ho Paik

6

1 reference

30 May 2018

Gheeyoung Choe

7

1 reference

30 May 2018

Jin-Haeng Chung

10

1 reference

30 May 2018

publication date

28 September 2012

1 reference

30 May 2018

published in

Histopathology

1 reference

30 May 2018

volume

62

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

305-314

1 reference

30 May 2018

New driver mutations in non-small-cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Targeting anaplastic lymphoma kinase in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Critical determinants of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Cancer metastasis: building a framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04356.X

10.1111/J.1365-2559.2012.04356.X

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018